NRC Health Future Growth

Future criteria checks 3/6

NRC Health is forecast to grow earnings and revenue by 49.8% and 6.4% per annum respectively while EPS is expected to grow by 49.2% per annum.

Key information

49.8%

Earnings growth rate

49.21%

EPS growth rate

Healthcare earnings growth	19.9%
Revenue growth rate	6.4%
Future return on equity	n/a
Analyst coverage	Low
Last updated	22 Jun 2026

Recent future growth updates

No updates

Recent updates

New Narrative • Jun 24

Experience Automation And Value-Based Care Tailwinds Will Support A Stronger Long-Term Outcome

Catalysts About NRC Health NRC Health provides experience measurement and improvement solutions that help health care organizations understand patients, families and caregivers and act on those insights. What are the underlying business or industry changes driving this perspective?

Seeking Alpha • Jan 03

National Research: The Turnaround Is Invisible Until It Isn't

Summary National Research Corp. is undervalued, trading at a modest multiple despite a clear pivot from contraction to growth. TRCV, NRC’s key forward metric, grew 8% YoY, signaling imminent revenue acceleration and a strong 2026 setup. Margins are expanding as cost structure is rationalized; normalized FCF could approach $38M in 2026 after one-off expenses subside. Industry consolidation and a revitalized sales force position NRC for upside, with a realistic path to $30+ per share as fundamentals re-rate. Read the full article on Seeking Alpha

Analysis Article • Nov 24

National Research Corporation's (NASDAQ:NRC) Shares Climb 51% But Its Business Is Yet to Catch Up

National Research Corporation ( NASDAQ:NRC ) shareholders would be excited to see that the share price has had a great...

Analysis Article • Oct 10

The Market Doesn't Like What It Sees From National Research Corporation's (NASDAQ:NRC) Earnings Yet As Shares Tumble 27%

National Research Corporation ( NASDAQ:NRC ) shareholders that were waiting for something to happen have been dealt a...

Analysis Article • Sep 26

Returns On Capital Signal Tricky Times Ahead For National Research (NASDAQ:NRC)

What are the early trends we should look for to identify a stock that could multiply in value over the long term...

Analysis Article • Aug 28

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation ( NASDAQ:NRC ) has announced that it will pay a dividend of $0.12 per share on the 10th...

Analysis Article • Aug 04

Risks Still Elevated At These Prices As National Research Corporation (NASDAQ:NRC) Shares Dive 26%

National Research Corporation ( NASDAQ:NRC ) shareholders won't be pleased to see that the share price has had a very...

Analysis Article • Jul 16

A Look At The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)

Key Insights Using the 2 Stage Free Cash Flow to Equity, National Research fair value estimate is US$14.74 National...

Analysis Article • Jun 20

There's Reason For Concern Over National Research Corporation's (NASDAQ:NRC) Massive 26% Price Jump

National Research Corporation ( NASDAQ:NRC ) shares have had a really impressive month, gaining 26% after a shaky...

Analysis Article • May 02

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

National Research Corporation ( NASDAQ:NRC ) has announced that it will pay a dividend of $0.12 per share on the 11th...

Analysis Article • Apr 22

Lacklustre Performance Is Driving National Research Corporation's (NASDAQ:NRC) 30% Price Drop

To the annoyance of some shareholders, National Research Corporation ( NASDAQ:NRC ) shares are down a considerable 30...

Analysis Article • Mar 28

National Research Corporation's (NASDAQ:NRC) Shares May Have Run Too Fast Too Soon

National Research Corporation's ( NASDAQ:NRC ) price-to-earnings (or "P/E") ratio of 21.9x might make it look like a...

Analysis Article • May 09

Estimating The Fair Value Of National Research Corporation (NASDAQ:NRC)

Key Insights National Research's estimated fair value is US$35.55 based on 2 Stage Free Cash Flow to Equity Current...

Analysis Article • Feb 20

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

National Research Corporation's ( NASDAQ:NRC ) investors are due to receive a payment of $0.12 per share on 15th of...

Earnings and Revenue Growth Forecasts

NasdaqGS:NRC - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2027	155	18	23	30	1
12/31/2026	142	8	19	26	1
3/31/2026	139	9	17	27	N/A
12/31/2025	137	11	16	26	N/A
9/30/2025	139	16	12	26	N/A
6/30/2025	140	18	9	21	N/A
3/31/2025	141	24	15	29	N/A
12/31/2024	143	25	19	35	N/A
9/30/2024	144	27	25	40	N/A
6/30/2024	146	29	23	40	N/A
3/31/2024	147	30	26	42	N/A
12/31/2023	149	31	22	38	N/A
9/30/2023	149	29	21	35	N/A
6/30/2023	148	29	21	35	N/A
3/31/2023	150	30	25	36	N/A
12/31/2022	152	32	26	36	N/A
9/30/2022	152	35	31	40	N/A
6/30/2022	152	36	32	39	N/A
3/31/2022	151	37	33	40	N/A
12/31/2021	148	37	41	46	N/A
9/30/2021	144	36	45	50	N/A
6/30/2021	140	36	47	52	N/A
3/31/2021	135	35	45	50	N/A
12/31/2020	133	37	37	41	N/A
9/30/2020	131	38	33	36	N/A
6/30/2020	130	36	35	39	N/A
3/31/2020	130	36	35	39	N/A
12/31/2019	128	32	N/A	41	N/A
9/30/2019	126	31	N/A	43	N/A
6/30/2019	124	30	N/A	38	N/A
3/31/2019	120	31	N/A	39	N/A
12/31/2018	120	30	N/A	40	N/A
9/30/2018	119	29	N/A	33	N/A
6/30/2018	118	26	N/A	36	N/A
3/31/2018	118	24	N/A	28	N/A
12/31/2017	118	23	N/A	28	N/A
9/30/2017	116	22	N/A	30	N/A
6/30/2017	114	23	N/A	26	N/A
3/31/2017	112	21	N/A	31	N/A
12/31/2016	109	20	N/A	27	N/A
9/30/2016	107	21	N/A	25	N/A
6/30/2016	106	20	N/A	24	N/A
3/31/2016	104	19	N/A	25	N/A
12/31/2015	102	17	N/A	22	N/A
9/30/2015	101	16	N/A	20	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NRC's forecast earnings growth (49.8% per year) is above the savings rate (3.5%).

Earnings vs Market: NRC's earnings (49.8% per year) are forecast to grow faster than the US market (18.6% per year).

High Growth Earnings: NRC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: NRC's revenue (6.4% per year) is forecast to grow slower than the US market (12.7% per year).

High Growth Revenue: NRC's revenue (6.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if NRC's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/04 02:47
End of Day Share Price	2026/07/02 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

NRC Health is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Constantine Davides	Citizens JMP Securities, LLC
Ryan Daniels	William Blair & Company L.L.C.

NRC Health Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Recent updates

Experience Automation And Value-Based Care Tailwinds Will Support A Stronger Long-Term Outcome

Upcoming dividend of US$0.16 per share

Investor sentiment deteriorates as stock falls 17%

Founder & Chairman recently sold US$5.0m worth of stock

NRC Health Brings Ambient Listening With Agentic AI To The Front Lines Of Leader Rounding

First quarter dividend of US$0.16 announced

NRC Health, Annual General Meeting, Jun 23, 2026

First quarter 2026 earnings released: EPS: US$0.15 (vs US$0.25 in 1Q 2025)

NRC Health Declares Quarterly Cash Dividend, Payable on July 10, 2026

National Research Corporation to Report Q1, 2026 Results on Apr 28, 2026

Upcoming dividend of US$0.16 per share

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

National Research Corporation (NasdaqGS:NRC) announces an Equity Buyback for $60 million worth of its shares.

Full year 2025 earnings released: EPS: US$0.50 (vs US$1.05 in FY 2024)

Chief Financial Officer recently bought US$98k worth of stock

Investor sentiment deteriorates as stock falls 30%

Fourth quarter dividend of US$0.16 announced

Full year 2025 earnings released: EPS: US$0.52 (vs US$1.05 in FY 2024)

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 10, 2026

National Research Corporation to Report Q4, 2025 Results on Feb 03, 2026

Founder exercised options to buy US$178k worth of stock.

National Research: The Turnaround Is Invisible Until It Isn't

Upcoming dividend of US$0.16 per share

National Research Corporation's (NASDAQ:NRC) Shares Climb 51% But Its Business Is Yet to Catch Up

Investor sentiment improves as stock rises 16%

NRC Health Appoints David Burik as Executive Vice President, Strategic Insights, Effective January 5, 2026

Investor sentiment improves as stock rises 17%

Third quarter dividend of US$0.16 announced

Third quarter 2025 earnings released: EPS: US$0.19 (vs US$0.24 in 3Q 2024)

National Research Corporation Declares Quarterly Cash Dividend, Payable on January 9, 2026

National Research Corporation to Report Q3, 2025 Results on Oct 27, 2025

The Market Doesn't Like What It Sees From National Research Corporation's (NASDAQ:NRC) Earnings Yet As Shares Tumble 27%

Investor sentiment deteriorates as stock falls 16%

Returns On Capital Signal Tricky Times Ahead For National Research (NASDAQ:NRC)

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corporation Appoints Shane Harrison as Its Incoming Executive Vice President, Effective on or About September 25, 2025

Investor sentiment improves as stock rises 18%

Risks Still Elevated At These Prices As National Research Corporation (NASDAQ:NRC) Shares Dive 26%

Second quarter dividend of US$0.12 announced

Second quarter 2025 earnings released: US$0.005 loss per share (vs US$0.26 profit in 2Q 2024)

National Research Corporation Declares Quarterly Cash Dividend, Payable on October 10, 2025

A Look At The Intrinsic Value Of National Research Corporation (NASDAQ:NRC)

There's Reason For Concern Over National Research Corporation's (NASDAQ:NRC) Massive 26% Price Jump

Upcoming dividend of US$0.12 per share

Insufficient new directors

Investor sentiment improves as stock rises 18%

National Research (NASDAQ:NRC) Has Affirmed Its Dividend Of $0.12

First quarter dividend of US$0.12 announced

First quarter 2025 earnings released: EPS: US$0.25 (vs US$0.27 in 1Q 2024)

National Research Corporation Declares A Quarterly Cash Dividend, Payable on July 11, 2025

Lacklustre Performance Is Driving National Research Corporation's (NASDAQ:NRC) 30% Price Drop

National Research Corporation, Annual General Meeting, May 07, 2025

Investor sentiment deteriorates as stock falls 15%

National Research (NASDAQ:NRC) Has Announced A Dividend Of $0.12

Fourth quarter dividend of US$0.12 announced

National Research Corporation Declares Quarterly Cash Dividend, Payable on April 11, 2025

Full year 2024 earnings released: EPS: US$1.05 (vs US$1.26 in FY 2023)

National Research Corporation Announces Chief Executive Officer Changes

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Full year 2024 earnings released: EPS: US$1.05 (vs US$1.26 in FY 2023)

National Research Corporation to Report Q4, 2024 Results on Jan 27, 2025

Founder exercised options to buy US$174k worth of stock.

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

Upcoming dividend of US$0.12 per share

National Research (NASDAQ:NRC) Is Due To Pay A Dividend Of $0.12

Investor sentiment improves as stock rises 15%

Third quarter dividend of US$0.12 announced

Third quarter 2024 earnings released: EPS: US$0.24 (vs US$0.32 in 3Q 2023)

National Research Corporation Appoints Helen L. Hrdy as Chief Operating Officer

Upcoming dividend of US$0.12 per share

NRC Health Launches First Ai-Enabled Solutions to Elevate Healthcare Experience

Dividend of US$0.12 announced

Second quarter 2024 earnings released: EPS: US$0.26 (vs US$0.30 in 2Q 2023)